Corneal Transplantation Market Size & Analysis | Report 2028

The corneal transplantation market is projected to reach US$ 640.79 million by 2028 from US$ 420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021 to 2028.

A cornea transplant (keratoplasty) is a surgical treatment that involves removing a portion of the cornea and replacing it with corneal tissue from a donor. The transparent, dome-shaped surface of the eye is known as the cornea. It is a large aspect of the eye's ability to see clearly because it is where light enters the eye. A cornea transplant can enhance the appearance of a damaged or diseased cornea while also restoring vision and reducing pain.

The growth of the corneal transplantation market is attributed to the increasing incidence of eye diseases, and the rising geriatric population. However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Corneal Transplantation Market: Strategic Insights

Corneal Transplantation Market

• 
  CAGR (2021 - 2028)

  6.2%
• Market Size 2021
  US$ 420.71 Million
• Market Size 2028
  US$ 640.79 Million

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• CorneaGen
• Alcon Inc
• Florida Lions Eye Bank
• Corneat Vision
• Aurolab
• KERAMED INC
• CORNEA BIOSCIENCES INC
• EYEMEDICS
• Massachusetts Eye and Ear

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Penetrating Keratoplasty
• Descemet Membrane Endothelial Keratoplasty

Descemet Stripping Endothelial Keratoplasty

• DSEK

Corneal Limbal Stem Cell Transplant, and Others)

Indication

• Fungal Corneal Ulcer
• Fuchs Dystrophy
• Keratoconus
• Keratitis
• Others End User

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Surge in Geriatric Population

The geriatric patient population is growing rapidly worldwide due to a significant rise in the subset of patients older than 80. According to the US Department of Health and Human Services, 54.1 million people were aged 65 and above in 2019 (up from 39.6 million in 2020). The population will reach 80.8 million by 2040 and 94.7 million by 2060. As the number of geriatric people increases, the demands of this group for healthcare services also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and a significant impact on vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Thus, the increase in the population of elderlies is driving the overall growth of the corneal transplant market.

Type-Based Insights

Based on type, the global corneal transplantation market has been segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the CAGR of 6.4% in the market during the forecast period.

Indication-Based Insights

Based on indication, the global corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 6.8% in the market during the forecast period.

Corneal Transplantation Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

End User -Based Insights

Based on end user, the Corneal Transplantations market is segmented hospitals, eye clinics, and ambulatory surgical centers. The hospital segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 6.1% in the market during the forecast period.

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the corneal transplantation market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.

Company Profiles

• CorneaGen
• Alcon Inc
• Florida Lions Eye Bank
• Corneat Vision
• Aurolab, Keramed, Inc.
• Cornea Biosciences, Inc.
• Eyemedics
• Massachusetts Eye and Ear
• Lifeline Scientific, Inc.
• San Diego Eye Bank